Literature DB >> 9627203

Prescribing of anti-epileptic drugs in the northern and Yorkshire region: 1992-1995.

S J Roberts1, M Feely, D N Bateman.   

Abstract

Epilepsy is a condition for which regular drug treatment is normally prescribed. We have examined the primary care prescribing rates for anti-epileptic drugs (AEDs) in a region of northern England with a population of 6.8 million. Over the 4-year period 1992-1995 the number of AED prescription items issued rose by 15%. A third of this rise is accounted for by increased prescribing of the new anticonvulsants, vigabatrin, lamotrigine and gabapentin, which are primarily indicated for adjunct use. Prescribing of phenytoin and barbiturates fell over the same period, but this reduction was more than compensated for by increased prescribing of carbamazepine and sodium valproate. There were notable differences in both the overall volume and the choice of AEDs used in different health authority areas and these are probably attributable to the influence of the local secondary-care sector on the therapeutic regimens adopted by general practitioners in the area.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9627203     DOI: 10.1016/s1059-1311(98)80068-x

Source DB:  PubMed          Journal:  Seizure        ISSN: 1059-1311            Impact factor:   3.184


  4 in total

1.  Volume and market share of anti-epileptic drugs in The Netherlands: impact of new drugs.

Authors:  Pieter Knoester; Charles Deckers; Ronald van der Vaart; Bert Leufkens; Yechiel Hekster
Journal:  Pharm World Sci       Date:  2005-04

Review 2.  Fortnightly review: drug treatment of epilepsy.

Authors:  M Feely
Journal:  BMJ       Date:  1999-01-09

3.  Prevalence, utilization, and costs of antiepileptic drugs for epilepsy in Germany--a nationwide population-based study in children and adults.

Authors:  Hajo M Hamer; Richard Dodel; Adam Strzelczyk; Monika Balzer-Geldsetzer; Jens-Peter Reese; Oliver Schöffski; Wolfgang Graf; Stefan Schwab; Susanne Knake; Wolfgang H Oertel; Felix Rosenow; Karel Kostev
Journal:  J Neurol       Date:  2012-04-28       Impact factor: 4.849

4.  Use and safety profile of antiepileptic drugs in Italy.

Authors:  M L Iorio; U Moretti; S Colcera; L Magro; I Meneghelli; D Motola; A L Rivolta; F Salvo; G P Velo
Journal:  Eur J Clin Pharmacol       Date:  2007-02-16       Impact factor: 2.953

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.